219 related articles for article (PubMed ID: 11278538)
1. Identification of critical residues in bovine IFNAR-1 responsible for interferon binding.
Cutrone EC; Langer JA
J Biol Chem; 2001 May; 276(20):17140-8. PubMed ID: 11278538
[TBL] [Abstract][Full Text] [Related]
2. Contributions of cloned type I interferon receptor subunits to differential ligand binding.
Cutrone EC; Langer JA
FEBS Lett; 1997 Mar; 404(2-3):197-202. PubMed ID: 9119063
[TBL] [Abstract][Full Text] [Related]
3. Mapping human interferon-alpha (IFN-alpha 2) binding determinants of the type I interferon receptor subunit IFNAR-1 with human/bovine IFNAR-1 chimeras.
Goldman LA; Cutrone EC; Dang A; Hao X; Lim JK; Langer JA
Biochemistry; 1998 Sep; 37(37):13003-10. PubMed ID: 9737881
[TBL] [Abstract][Full Text] [Related]
4. Bovine type I interferon receptor protein BoIFNAR-1 has high-affinity and broad specificity for human type I interferons.
Langer JA; Yang J; Carmillo P; Ling LE
FEBS Lett; 1998 Jan; 421(2):131-5. PubMed ID: 9468293
[TBL] [Abstract][Full Text] [Related]
5. Structure-function study of the extracellular domain of the human type I interferon receptor (IFNAR)-1 subunit.
Kumaran J; Colamonici OR; Fish EN
J Interferon Cytokine Res; 2000 May; 20(5):479-85. PubMed ID: 10841076
[TBL] [Abstract][Full Text] [Related]
6. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution of a high affinity binding site for type I interferons.
Russell-Harde D; Pu H; Betts M; Harkins RN; Perez HD; Croze E
J Biol Chem; 1995 Nov; 270(44):26033-6. PubMed ID: 7592797
[TBL] [Abstract][Full Text] [Related]
8. The human interferon receptor: NMR-based modeling, mapping of the IFN-alpha 2 binding site, and observed ligand-induced tightening.
Chill JH; Nivasch R; Levy R; Albeck S; Schreiber G; Anglister J
Biochemistry; 2002 Mar; 41(11):3575-85. PubMed ID: 11888273
[TBL] [Abstract][Full Text] [Related]
9. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
10. Domains of interaction between alpha interferon and its receptor components.
Uzé G; Di Marco S; Mouchel-Vielh E; Monneron D; Bandu MT; Horisberger MA; Dorques A; Lutfalla G; Mogensen KE
J Mol Biol; 1994 Oct; 243(2):245-57. PubMed ID: 7932753
[TBL] [Abstract][Full Text] [Related]
11. Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2.
Chuntharapai A; Gibbs V; Lu J; Ow A; Marsters S; Ashkenazi A; De Vos A; Jin Kim K
J Immunol; 1999 Jul; 163(2):766-73. PubMed ID: 10395669
[TBL] [Abstract][Full Text] [Related]
12. Activity of hybrid type I interferons in cells lacking Tyk2: a common region of IFN-alpha 8 induces a response, but IFN-alpha2/8 hybrids can behave like IFN-beta.
Platis D; Foster GR
J Interferon Cytokine Res; 2003 Nov; 23(11):655-66. PubMed ID: 14651780
[TBL] [Abstract][Full Text] [Related]
13. Mapping of IFN-beta epitopes important for receptor binding and biologic activation: comparison of results achieved using antibody-based methods and alanine substitution mutagenesis.
Runkel L; De Dios C; Karpusas M; Baker D; Li Z; Zafari M; Betzenhauser M; Muldowney C; Miller S; Redlich PN; Grossberg SE; Whitty A; Hochman PS
J Interferon Cytokine Res; 2001 Nov; 21(11):931-41. PubMed ID: 11747625
[TBL] [Abstract][Full Text] [Related]
14. Homology model of human interferon-alpha 8 and its receptor complex.
Seto MH; Harkins RN; Adler M; Whitlow M; Church WB; Croze E
Protein Sci; 1995 Apr; 4(4):655-70. PubMed ID: 7613464
[TBL] [Abstract][Full Text] [Related]
15. Mutation of the IFNAR-1 receptor binding site of human IFN-alpha2 generates type I IFN competitive antagonists.
Pan M; Kalie E; Scaglione BJ; Raveche ES; Schreiber G; Langer JA
Biochemistry; 2008 Nov; 47(46):12018-27. PubMed ID: 18937499
[TBL] [Abstract][Full Text] [Related]
16. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
Piehler J; Schreiber G
J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041
[TBL] [Abstract][Full Text] [Related]
17. Evidence for glycosphingolipid modification of the type 1 IFN receptor.
Ghislain J; Lingwood CA; Fish EN
J Immunol; 1994 Oct; 153(8):3655-63. PubMed ID: 7930586
[TBL] [Abstract][Full Text] [Related]
18. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.
Lamken P; Gavutis M; Peters I; Van der Heyden J; Uzé G; Piehler J
J Mol Biol; 2005 Jul; 350(3):476-88. PubMed ID: 15946680
[TBL] [Abstract][Full Text] [Related]
19. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta.
Abramovich C; Shulman LM; Ratovitski E; Harroch S; Tovey M; Eid P; Revel M
EMBO J; 1994 Dec; 13(24):5871-7. PubMed ID: 7813427
[TBL] [Abstract][Full Text] [Related]
20. N-glycosylation of murine IFN-beta in a putative receptor-binding region.
Sommereyns C; Michiels T
J Interferon Cytokine Res; 2006 Jun; 26(6):406-13. PubMed ID: 16734561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]